Newsroom

The SPARK | REACH Program is the go-to program on campus for anyone who has promising proof-of-concept data in the lab. SPARK helps develop technologies that address unmet medical needs and will open for new applications on June 19.

The event was sponsored by CU Innovations, the university’s bridge between cutting-edge technologies developed on campus and industry partners, entrepreneurs and investors. It was held in the Donald M. Elliman Conference Center in the Anschutz Health Sciences Building.

CU Innovations offers an exceptional experience for graduate students, providing them with the opportunity to immerse themselves in the department and become valuable contributors to the CU Anschutz Medical Campus innovation ecosystem.

As the Director of Faculty Ventures, Dr. Holers is now helping CU Innovations deepen its faculty and trainee relationships to better facilitate the very process of translating discoveries into patient impact.

Kim Muller is the Executive Director of CU Innovations, the technology commercialization and venture development office at the University of Colorado’s Anschutz Medical and Denver campuses. VIC recently had a chance to discuss the overall topic of supporting the translation of cutting-edge research.

Royal Philips , a global leader in health technology, and BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, announced they have been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly USD 2.8 million from the U.S. Department of Defense (DoD) through a Medical Technology Enterprise Consortium (MTEC) award to validate BioIntelliSense’s FDA-cleared BioSticker device for the early detection of COVID-19 symptoms. The goal of the award is to accelerate the use of wearable diagnostics for the benefit of military and public health through the early identification and containment of pre-symptomatic COVID-19 cases.

Aurora, Colo., Dec. 17, 2020 (GLOBE NEWSWIRE) -- As UCHealth begins administering the Pfizer COVID-19 vaccine to health care workers today at University of Colorado Hospital on the University of Colorado Anschutz Medical Campus, some recipients will be wearing the BioIntelliSense BioButton medical device as a foundational step in developing a scalable post-vaccine monitoring program that could be deployed more broadly in high-risk patient populations.

Universities across the country are celebrating today the 40th anniversary of the Patent and Trademark Amendments Act of 1980, better known as the “Bayh-Dole Act” after its sponsors. The Bayh-Dole was historic because it created a uniform federal intellectual property policy for inventions created at universities and other federally-funded institutions. This allows universities to own the intellectual property covering their research, which enables them to develop and commercialize their discoveries in order to bring them to the public.